Dosage Forms

Articles

Hermes Pharma has commercially implemented hot-melt coating (HMC) technology at its production facility.

Hermes Pharma Adds Hot Melt Coating Capability

With the acquisition of Medipac’s tube filling assets for effervescent tablets, Romaco can now offer the complete line configurations for effervescent tablets.

Romaco Acquires Medipac AB and Extends Position in Effervescent Tablets Sector

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Integrated pharmaceutical blister-packaging equipment systems strengthen serialization and brand protection capabilities.

New Equipment Improves Blister Packaging

Dynamic powder testing and measurement of bulk powder properties can complement shear cell testing to identify the causes of poor hopper performance in solid-dosage drug manufacturing.

Best Practices for Optimizing Hopper Performance

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Experts at the ISPE annual meeting describe best practices, including containment and production in classified spaces.

Modernizing Oral Solid-Dosage Manufacturing

AstraZeneca’s solid-dose facility in Taizhou, China received ISPE’s FOYA 2015 Overall Winner award.

AstraZeneca China Wins ISPE Facility of the Year Award

A rheometer and powder flow tester can measure how pharmaceutical materials, such as powders from a hopper, flow.

Understanding the Flow Behavior of Materials

The FDA grants to the Rutgers-led C-SOPS research consortium will support the introduction of continuous manufacturing techniques for pharmaceuticals.

FDA Awards Grants to Expand Continuous Manufacturing

Hovione is investing in specialized formulation capabilities, beginning with the acquisition of a formulation facility adjacent to the current process chemistry and particle engineering facility in Loures, Portugal, the company announced on Oct. 19, 2015. This acquisition is a strategic investment to further boost development and manufacturing capabilities for both inhalation and oral dosage forms.

Hovione Expands Formulation Capabilities

At CPhI Worldwide 2015, The Dow Chemical Company announced the global commercial availability of AFFINISOL HPMC HME, a new generation of cellulosic polymer for drug solubilization. The polymer is designed for use by pharmaceutical companies looking to enhance the solubilization and inhibit the recrystallization of APIs in hot-melt extrusion (HME) formulations.

Solid/Semi-Solid Dosage